1. Home
  2. ALLK vs GFAI Comparison

ALLK vs GFAI Comparison

Compare ALLK & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • GFAI
  • Stock Information
  • Founded
  • ALLK 2012
  • GFAI 2018
  • Country
  • ALLK United States
  • GFAI Singapore
  • Employees
  • ALLK N/A
  • GFAI N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • ALLK Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • ALLK Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • ALLK 23.0M
  • GFAI 20.7M
  • IPO Year
  • ALLK 2018
  • GFAI N/A
  • Fundamental
  • Price
  • ALLK $0.33
  • GFAI $1.02
  • Analyst Decision
  • ALLK Hold
  • GFAI Strong Buy
  • Analyst Count
  • ALLK 3
  • GFAI 2
  • Target Price
  • ALLK $2.00
  • GFAI $6.75
  • AVG Volume (30 Days)
  • ALLK 2.2M
  • GFAI 287.8K
  • Earning Date
  • ALLK 05-08-2025
  • GFAI 05-06-2025
  • Dividend Yield
  • ALLK N/A
  • GFAI N/A
  • EPS Growth
  • ALLK N/A
  • GFAI N/A
  • EPS
  • ALLK N/A
  • GFAI N/A
  • Revenue
  • ALLK N/A
  • GFAI $35,841,743.00
  • Revenue This Year
  • ALLK N/A
  • GFAI $0.37
  • Revenue Next Year
  • ALLK N/A
  • GFAI $5.60
  • P/E Ratio
  • ALLK N/A
  • GFAI N/A
  • Revenue Growth
  • ALLK N/A
  • GFAI 1.78
  • 52 Week Low
  • ALLK $0.22
  • GFAI $0.76
  • 52 Week High
  • ALLK $1.56
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 60.40
  • GFAI 49.80
  • Support Level
  • ALLK $0.31
  • GFAI $0.93
  • Resistance Level
  • ALLK $0.33
  • GFAI $1.07
  • Average True Range (ATR)
  • ALLK 0.00
  • GFAI 0.09
  • MACD
  • ALLK 0.00
  • GFAI 0.02
  • Stochastic Oscillator
  • ALLK 78.50
  • GFAI 83.87

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Share on Social Networks: